S&CO Inc’s Amgen AMGN Stock Holding History

S&CO Inc’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Hold	834	–	–	0.02%	193
2025 Q4	$272K	Hold	834	–	–	0.02%	197
2025 Q3	$235K	Hold	834	–	–	0.01%	212
2025 Q2	$232K	Hold	834	–	–	0.01%	213
2025 Q1	$259K	Hold	834	–	–	0.02%	199
2024 Q4	$217K	Hold	834	–	–	0.01%	204
2024 Q3	$268K	Hold	834	–	–	0.02%	199
2024 Q2	$260K	Hold	834	–	–	0.02%	198
2024 Q1	$237K	Hold	834	–	–	0.02%	195
2023 Q4	$240K	Hold	834	–	–	0.02%	177
2023 Q3	$224K	Buy	+834	New	+$208K	0.02%	167
2023 Q2	–	Sell	-834	Closed	-$201K	–	183
2023 Q1	$201K	Hold	834	–	–	0.02%	175
2022 Q4	$219K	Buy	+834	New	+$224K	0.02%	169
2022 Q3	–	Sell	-834	Closed	-$202K	–	185
2022 Q2	$202K	Buy	834 +4	+0.5%	+$980	0.02%	183
2022 Q1	$200K	Buy	+830	New	+$191K	0.01%	187
2021 Q3	–	Sell	-830	Closed	-$202K	–	188
2021 Q2	$202K	Hold	830	–	–	0.02%	184
2021 Q1	$206K	Buy	+830	New	+$198K	0.02%	180
2020 Q4	–	Sell	-830	Closed	-$211K	–	182
2020 Q3	$211K	Buy	+830	New	+$206K	0.02%	170
2020 Q1	–	Sell	-830	Closed	-$200K	–	169
2019 Q4	$200K	Buy	+830	New	+$183K	0.02%	175
2018 Q3	–	Sell	-19,630	Closed	-$3.62M	–	187
2018 Q2	$3.62M	Sell	19,630 -23	-0.1%	-$4.07K	0.44%	52
2018 Q1	$3.35M	Buy	19,653 +53	+0.3%	+$9.73K	0.42%	53
2017 Q4	$3.41M	Hold	19,600	–	–	0.42%	54
2017 Q3	$3.65M	Buy	19,600 +1,000	+5%	+$177K	0.47%	51
2017 Q2	$3.2M	Hold	18,600	–	–	0.42%	55
2017 Q1	$3.05M	Sell	18,600 -660	-3%	-$110K	0.42%	53
2016 Q4	$2.82M	Buy	19,260 +660	+4%	+$99.3K	0.41%	55
2016 Q3	$3.1M	Sell	18,600 -1,000	-5%	-$169K	0.47%	49
2016 Q2	$2.98M	Buy	19,600 +1,000	+5%	+$155K	0.46%	52
2016 Q1	$2.79M	Sell	18,600 -100	-0.5%	-$14.9K	0.45%	50
2015 Q4	$3.04M	Hold	18,700	–	–	0.51%	46
2015 Q3	$2.59M	Buy	18,700 +100	+0.5%	+$15.8K	0.45%	51
2015 Q2	$2.85M	Hold	18,600	–	–	0.42%	54
2015 Q1	$2.97M	Hold	18,600	–	–	0.42%	54
2014 Q4	$2.96M	Hold	18,600	–	–	0.43%	54
2014 Q3	$2.61M	Hold	18,600	–	–	0.4%	52
2014 Q2	$2.2M	Hold	18,600	–	–	0.31%	55
2014 Q1	$2.29M	Hold	18,600	–	–	0.34%	56
2013 Q4	$2.12M	Hold	18,600	–	–	0.35%	53
2013 Q3	$2.08M	Hold	18,600	–	–	0.37%	52
2013 Q2	$1.83M	Buy	+18,600	New	+$1.93M	0.28%	56

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

S&CO Inc's AMGN Position: Q1 2026 in Review

S&CO Inc held its Amgen (AMGN) position steady in Q1 2026 at 834 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #193.

S&CO Inc first reported a position in AMGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $3.65M in Q3 2017. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

S&CO Inc held 834 shares of Amgen worth $293K as of Q1 2026.
S&CO Inc left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.02% of S&CO Inc's portfolio in Q1 2026, its #193 holding.
S&CO Inc first reported a position in Amgen in Q2 2013 and has held it in 40 quarters since.
S&CO Inc's Amgen position peaked at $3.65M in Q3 2017.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.